Endocrinology, Vol 133, 1092-1097, Copyright © 1993 by Endocrine Society

ARTICLES

Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells

HJ Frank, ER Levin, RM Hu and A Pedram
Department of Medicine and Pharmacology, University of California, Irvine 92717.

Hyperinsulinemia has been implicated as a separate risk factor for the development of accelerated cardiovascular disease, but the mechanism is unknown. Recently, we and several other groups have shown that insulin stimulates the production and secretion of the vasoconstrictor peptide endothelin-1 (ET-1) from vascular endothelial cells, and hyperinsulinemia results in increased plasma ET levels in vivo. However, the interactive effects of diabetes, insulin, and glucose on ET target tissues, like those on vascular smooth muscle cells (VSMC), are not well defined. In these studies, we examined the effects of the diabetic factors on ET receptors and [3H]thymidine incorporation into cultured cells prepared from control, streptozocin-diabetic, insulin- treated diabetic, and hyperinsulinemic rats. Scatchard analysis of saturation binding studies revealed a 2-fold increase in ET receptor number in normal VSMC treated in vitro with insulin, whereas glucose had no significant effect. Neither treatment affected receptor affinity. Similarly, aortic smooth muscle cells, brain capillary pericytes, and kidney afferent arteriolar smooth muscle cells from rats made hyperinsulinemic in vivo each showed approximately a 2-fold increase in receptor number. This increase in receptor density probably resulted from the stimulation of receptor protein production, because insulin caused a maximal 2.3 +/- 0.3 (+/- SEM) fold increase in the ETA receptor mRNA expressed in cultured VSMC by 4 h. Both insulin and ET significantly increased thymidine incorporation in aortic VSMC, but ET- 1 was much more potent in this regard. However, the combined effects of insulin plus ET-1 resulted in a 10-fold increase in this index of cell proliferation, significantly different from the effects of either peptide alone. We postulate that hyperinsulinemia in vivo may potentiate ET release and receptor-mediated action, thereby contributing to vascular disease in the setting of diabetes.

This article has been cited by other articles:

				P. A. Sarafidis and G. L. Bakris Insulin and Endothelin: An Interplay Contributing to Hypertension Development? J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 379 - 385. [Abstract] [Full Text] [PDF]

				E. C. Eringa, C. D.A. Stehouwer, T. Merlijn, N. Westerhof, and P. Sipkema Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles Cardiovasc Res, December 1, 2002; 56(3): 464 - 471. [Abstract] [Full Text] [PDF]

				C. Ang, C. Hillier, A. D. Cameron, I. A. Greer, and M. A. Lumsden The Effect of Type 1 Diabetes Mellitus on Vascular Responses to Endothelin-1 in Pregnant Women J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4939 - 4942. [Abstract] [Full Text] [PDF]

				D. Galipeau, E. Arikawa, I. Sekirov, and J. H. McNeill Chronic Thromboxane Synthase Inhibition Prevents Fructose-Induced Hypertension Hypertension, October 1, 2001; 38(4): 872 - 876. [Abstract] [Full Text] [PDF]

				S. Verma, L. Yao, D. J. Stewart, A. S. Dumont, T. J. Anderson, and J. H. McNeill Endothelin Antagonism Uncovers Insulin-Mediated Vasorelaxation In Vitro and In Vivo Hypertension, February 1, 2001; 37(2): 328 - 333. [Abstract] [Full Text] [PDF]

				M. Santure, M. Pitre, N. Gaudreault, A. Marette, A. Nadeau, and H. Bachelard Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G682 - G692. [Abstract] [Full Text] [PDF]

				S.-Q. Wu, R. L Hopfner, J.R. McNeill, T. W Wilson, and V. Gopalakrishnan Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat Cardiovasc Res, March 1, 2000; 45(4): 994 - 1000. [Abstract] [Full Text] [PDF]

				H. Gobel, C. Ihling, J. Dentz, H. E. Schaefer, A. M. Zeiher, and G. Fraedrich Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 367 - 372. [Abstract] [Full Text] [PDF]

				Z. K. Krowicki, N. A. Nathan, and P. J. Hornby Gastric motor and cardiovascular effects of insulin in dorsal vagal complex of the rat Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G964 - G972. [Abstract] [Full Text] [PDF]

				D. Hasdai, D. R. Holmes Jr., D. M. Richardson, U. Izhar, and A. Lerman Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Cardiovasc Res, September 1, 1998; 39(3): 644 - 650. [Abstract] [Full Text] [PDF]

				A. K. Morey, A. Pedram, M. Razandi, B. A. Prins, R.-M. Hu, E. Biesiada, and E. R. Levin Estrogen and Progesterone Inhibit Vascular Smooth Muscle Proliferation Endocrinology, August 1, 1997; 138(8): 3330 - 3339. [Abstract] [Full Text] [PDF]

				A. Pedram, M. Razandi, R.-M. Hu, and E. R. Levin Vasoactive Peptides Modulate Vascular Endothelial Cell Growth Factor Production and Endothelial Cell Proliferation and Invasion J. Biol. Chem., July 4, 1997; 272(27): 17097 - 17103. [Abstract] [Full Text] [PDF]

				E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF]

				Y. Xiong, H. Tanaka, J. A. Richardson, S. C. Williams, C. A. Slaughter, M. Nakamura, J.-L. Chen, and M. Yanagisawa Endothelin-1 Stimulates Leptin Production in Adipocytes J. Biol. Chem., July 20, 2001; 276(30): 28471 - 28477. [Abstract] [Full Text] [PDF]